Clinical Trial Update: Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether intravenous ketorolac reduces opioid use, estimated blood loss, and complications after cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstetrical Analgesia
• Postoperative Pain
• Postpartum Hemorrhage

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Analgesia, Obstetrical, Postpartum Hemorrhage | Phase 4 | Status: COMPLETED | Results posted: 2022-06-07